BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17495531)

  • 1. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
    Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
    Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
    Leng X; Noble M; Adams PD; Qin J; Harper JW
    Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition.
    Cheng KY; Noble ME; Skamnaki V; Brown NR; Lowe ED; Kontogiannis L; Shen K; Cole PA; Siligardi G; Johnson LN
    J Biol Chem; 2006 Aug; 281(32):23167-79. PubMed ID: 16707497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.
    Schulman BA; Lindstrom DL; Harlow E
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10453-8. PubMed ID: 9724724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural prediction of the interaction of the tumor suppressor p27
    Li J; Vervoorts J; Carloni P; Rossetti G; Lüscher B
    BMC Bioinformatics; 2017 Jan; 18(1):15. PubMed ID: 28056778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of human cyclin B.
    Petri ET; Errico A; Escobedo L; Hunt T; Basavappa R
    Cell Cycle; 2007 Jun; 6(11):1342-9. PubMed ID: 17495533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.
    Zheng F; Quiocho FA
    J Biol Chem; 2013 Oct; 288(42):30682-30692. PubMed ID: 24022486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex.
    De Vivo M; Cavalli A; Bottegoni G; Carloni P; Recanatini M
    Proteins; 2006 Jan; 62(1):89-98. PubMed ID: 16292742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
    Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
    Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Conformational Dynamics and Expansion Underpin a Multi-Step Mechanism for Specific Binding of p27 with Cdk2/Cyclin A.
    Tsytlonok M; Hemmen K; Hamilton G; Kolimi N; Felekyan S; Seidel CAM; Tompa P; Sanabria H
    J Mol Biol; 2020 Apr; 432(9):2998-3017. PubMed ID: 32088186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the ORC1-Cyclin A association.
    Wang B; Song J
    Protein Sci; 2019 Sep; 28(9):1727-1733. PubMed ID: 31309634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A; Gerry S; Kaldis P; Solomon MJ
    BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of cyclin A.
    Brown NR; Noble ME; Endicott JA; Garman EF; Wakatsuki S; Mitchell E; Rasmussen B; Hunt T; Johnson LN
    Structure; 1995 Nov; 3(11):1235-47. PubMed ID: 8591034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.